4-氟苯磺酰基乙腈 | 32083-66-2

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟苯腈系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氟苯磺酰基乙腈
• 中文别名: (4-氟苯磺酰基)乙腈
• 英文名称: 2-((4-fluorophenyl)sulfonyl)acetonitrile
• 英文别名: 2-(4-fluoro-benzenesulfonyl)acetonitrile；(4-fluoro-benzenesulphonyl)-acetonitrile；[(4-Fluorophenyl)sulfonyl]acetonitrile；2-(4-fluorophenyl)sulfonylacetonitrile
• CAS: 32083-66-2
• 化学式: C₈H₆FNO₂S
• mdl: MFCD00179339
• 分子量: 199.206
• InChiKey: WBXJZTLPEMITJL-UHFFFAOYSA-N

物化性质

• 熔点：
  87 °C
• 沸点：
  390.5±42.0 °C(Predicted)
• 密度：
  1.370±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  如果按照规定使用和储存，则不会分解，没有已知的危险反应。应避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  66.3
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  6.1
• 危险品标志：
  Xn
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22,R36/37/38
• 危险品运输编号：
  3276
• 海关编码：
  2926909090
• 包装等级：
  III
• 危险类别：
  6.1

SDS

Name:	2-[(4-Fluorophenyl)sulfonyl]acetonitrile 97% Material Safety Data Sheet
Synonym:
CAS:	32083-66-2

Section 1 - Chemical Product MSDS Name:2-[(4-Fluorophenyl)sulfonyl]acetonitrile 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
32083-66-2	2-[(4-Fluorophenyl)sulfonyl]acetonitri	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 32083-66-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 87 - 89 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H6FNO2S
Molecular Weight: 199

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 32083-66-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-[(4-Fluorophenyl)sulfonyl]acetonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 32083-66-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 32083-66-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 32083-66-2 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氟苯磺酰基乙腈 在 吡啶 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 乙醇 、 乙腈 为溶剂， 反应 34.0h， 生成 2,2,2-trifluoro-N-[3-(4-fluorophenyl)sulfonyl-2-thienyl]acetamide
  参考文献：
  名称：

  Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones

  摘要：

  Based on general SARs previously described for anti-HIV-l diarylsulfone derivatives, a series of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes has been prepared and evaluated as potential antiviral and antitumor agents. In cell culture, some of the 2-aminothiophenes exhibited moderate and selective activity against HIV-1, with 2-amino-3-(2-nitrophenylsulfonyl)thiophene (7e) being most attractive (EC50 = 3.8 mug/mL: CC50 = > 100 mug/mL). In broad-spectrum antiviral assays, the 3-arylsulfonyl-2-(trifluoroacetamido)thio (8c-g) and 2-acetamido-3-arylsulfonyl-5-nitrothiophenes (9f-g) proved considerably active (IC50 = 0.1-10 mug/mL) against human cytomegalovirus (CMV) and/or varicella tester virus (VZV). Based on the activity of the trifluoroacetamides, ring-modified furan, N-(substituted)pyrrole, phenyl, and 3,4-thiophene analogues were prepared, and these compounds were also active against CMV and/or VZV, with the notable exception of the 3,4-thiophene derivative. In contrast to other amines, the 2-aminopyrrole precursors (13a-d) also exhibited potent activity against CMV. Unfortunately, most of these compounds displayed significant cytotoxicity against human fibroblasts, the cells supporting CMV and VZV replication, and thus selectivity indices were low. The most notable exception to this was the naphthyl-substituted aminopyrrole 13d, which exhibited both potent (IC50 = 0.3 mug/mL) and selective (CC50 = > 50 mug/mL) activity against CMV. Finally, thiophene aryl amides 8i-k displayed moderate in vitro activity against certain leukemia, breast, and colon cancer cell lines. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(00)00333-3
• 作为产物：
  描述：

  对氟苯硫酚 在 sodium carbonate 、 间氯过氧苯甲酸 作用下， 以 二氯甲烷 、 丙酮 为溶剂， 反应 12.0h， 生成 4-氟苯磺酰基乙腈
  参考文献：
  名称：

  铑（I）催化芳基硼酸加成至（苄基-/芳基磺酰基）乙腈：（Z）-β-磺酰基乙烯基胺和β-酮基砜的高效合成

  摘要：

  描述了一种有效的铑（I）催化的芳基硼酸加成到（苄基-/芳基磺酰基）乙腈中。以立体选择性的方式（Z-烯烃）形成新的β-磺酰基乙烯基胺产物。水解后，可获得有用的具有广泛范围的芳基和磺酰基取代基的β-酮砜。

  DOI：

  10.1021/ol102598p

文献信息

• [EN] LOX INHIBITORS<br/>[FR] INHIBITEURS DE LOX
  申请人：THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL

  公开号：WO2020099886A1

  公开（公告）日：2020-05-22

  The disclosure relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, Formula (I) as defined herein. Compounds according to Formula I are pharmacologically effective as lysyl oxidase (LOX) inhibitors and are believed to be useful in the treatment of, for instance, cancer.

  该披露涉及到公式I的化合物，或其药用盐，公式(I)如本文所定义。根据公式I的化合物在药理学上作为赖氨酸氧化酶（LOX）抑制剂具有药效，并被认为在癌症治疗中是有用的。
• QUINOXALINE-BASED LXR MODULATORS
  申请人：Hu Baihua

  公开号：US20100120778A1

  公开（公告）日：2010-05-13

  Disclosed are quinoxaline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): wherein: each of L 1 and L 2 is, independently, a bond, —O— or —NH—; R 2 is C 6 -C 10 aryl or heteroaryl including 5-10 atoms, each of which is (i) substituted with 1 R 9 , and (ii) optionally further substituted with from 1-4 R e ; and each of R 4 and R 5 is, independently (i) hydrogen; or (ii) halo; or (iii) C 1 -C 6 alkyl or C 1 -C 6 haloalkyl, each of which is optionally substituted with from 1-3 R a ; and R 1 , R 3 , R 6 , R 9 , R a and R e are defined herein. In general, these compounds can be used for treating or preventing one or more diseases, disorders, conditions or symptoms mediated by LXRs.

  公开了基于喹诺克的Liver X受体（LXRs）调节剂及相关方法。这些调节剂包括以下式（I）的化合物： 其中： L1和L2分别独立为键，-O-或-NH-； R2是C6-C10的芳基或杂芳基，包括5-10个原子，每个原子（i）带有1个R9基团，和（ii）可选地带有1-4个Re基团； R4和R5分别独立为（i）氢；（ii）卤素；或（iii）C1-C6的烷基或C1-C6的卤代烷基，每个都可选地带有1-3个Ra基团； 以及R1、R3、R6、R9、Ra和Re都在此定义。 一般来说，这些化合物可用于治疗或预防一个或多个由LXRs介导的疾病、失调、状况或症状。
• [EN] 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE 2-AMINO-INDOLE 3-SUBSTITUÉS
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2015198045A1

  公开（公告）日：2015-12-30

  The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X% X4,X5 X6, X7,R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.

  本发明提供了公式(I)（公式(I)）的化合物及其药用可接受的盐，其中Q，X，X4，X5，X6，X7，R1，R2，R3和R8如说明书中所定义，这些化合物的制备方法，包含它们的药物组合物以及这些化合物在治疗中的用途。
• COMPOSITION, SYNTHESIS, AND USE OF NEW ARYLSULFONYL ISONITRILES
  申请人：DUQUESNE UNIVERSITY OF THE HOLY GHOST

  公开号：US20150239833A1

  公开（公告）日：2015-08-27

  This invention relates to novel isonitriles, including arylsulfonyl isonitriles, and methods for their synthesis. The isonitriles include a conjugated ring system. The structure is designed with the flexibility to have multiple substitution patterns. The isonitriles may be used in applications including, but not limited to, pharmaceutical compositions.

  这项发明涉及新型异腈，包括芳基磺酰异腈，以及它们的合成方法。异腈包括一个共轭环系统。该结构设计具有多种取代模式的灵活性。异腈可用于包括但不限于药物组合物在内的应用中。
• A Concise Route to 2‐Sulfonylacetonitriles from Sodium Metabisulfite
  作者：Yanfang Yao、Ziqing Yin、Weiyun Chen、Wenlin Xie、Fu‐Sheng He、Jie Wu

  DOI：10.1002/adsc.202001243

  日期：2021.1.19

  A three‐component reaction of aryldiazonium tetrafluoroborates, sodium metabisulfite, and 3‐azido‐2‐methylbut‐3‐en‐2‐ol under mild conditions is described. By using abundant and cheap sodium metabisulfite as the sulfur dioxide surrogate, this protocol features good functional group compatibility, affording 2‐arylsulfonylacetonitriles in moderate to good yields. The reaction proceeds smoothly at room

  描述了在温和条件下四氟硼酸芳基重氮，偏亚硫酸氢钠和3-叠氮基-2-甲基丁-3-烯-2-醇的三组分反应。通过使用大量廉价的焦亚硫酸钠作为二氧化硫替代品，该方案具有良好的官能团相容性，可提供中等至良好收率的2-芳基磺酰基乙腈。反应在室温下平稳进行，不需要任何催化剂或添加剂。此外，该方法的合成效用通过将2-芳基磺酰基乙腈转化为2-芳基磺酰基乙酰胺和2-芳基磺酰基乙胺得到了证明。

表征谱图